(20S)-Protopanaxatriol - CAS 34080-08-5
Catalog number: 34080-08-5
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C30H52O4
Molecular Weight:
476.73
COA:
Inquire
Targets:
Others
Description:
20S-Protopanaxatriol (g-PPT), a dammarane-type tetracyclic terpene sapogenin, may be used to study its binding to and modulation of cell function via glucocortoid (GR) and oestrogen (ER) receptors.
Purity:
>98%
Synonyms:
20(S)-APPT; g-PPT
MSDS:
Inquire
InChIKey:
SHCBCKBYTHZQGZ-CJPZEJHVSA-N
InChI:
InChI=1S/C30H52O4/c1-18(2)10-9-13-30(8,34)19-11-15-28(6)24(19)20(31)16-22-27(5)14-12-23(33)26(3,4)25(27)21(32)17-29(22,28)7/h10,19-25,31-34H,9,11-17H2,1-8H3/t19-,20+,21-,22+,23-,24-,25-,27+,28+,29+,30-/m0/s1
Canonical SMILES:
CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)O)C)O)C)O)C
1.Both GPER and membrane oestrogen receptor-α activation protect ventricular remodelling in 17β oestradiol-treated ovariectomized infarcted rats.
Lee TM1, Lin SZ, Chang NC. J Cell Mol Med. 2014 Dec;18(12):2454-65. doi: 10.1111/jcmm.12430. Epub 2014 Sep 25.
Clinical and experimental studies have established that gender is a factor in the development of ventricular hypertrophy. We investigated whether the attenuated hypertrophic effect of oestradiol was via activation of phosphatidylinositol 3-kinase (PI3K)/Akt/endothelial nitric oxide synthase (eNOS) through non-genomic action. Twenty-four hours after coronary ligation, female Wistar rats were randomized into control, subcutaneous oestradiol treatment or a G-protein coupled oestrogen receptor (GPER) agonist, G-1 and treated for 4 weeks starting from 2 weeks after bilateral ovariectomy. Ventricular hypertrophy assessed by cardiomyocyte size after infarction was similarly attenuated by oestradiol or G-1 in infarcted rats. The phosphorylation of Akt and eNOS was significantly decreased in infarcted rats and restored by oestradiol and G-1, implying the GPER pathway in this process. Oestradiol-induced Akt phosphorylation was not abrogated by G-15 (a GPER blocker).
2.Identification of 20(S)-protopanaxatriol metabolites in rats by ultra-performance liquid chromatography coupled with electrospray ionization quadrupole time-of-flight tandem mass spectrometry and nuclear magnetic resonance spectroscopy.
He C1, Zhou D, Li J, Han H, Ji G, Yang L, Wang Z. J Pharm Biomed Anal. 2014 Jan;88:497-508. doi: 10.1016/j.jpba.2013.09.031. Epub 2013 Oct 14.
20(S)-Protopanaxatriol (PPT), one of the aglycones of ginsenosides, has been shown to exert cardioprotective effects against myocardial ischemic injury. However, studies on PPT metabolism have rarely been reported. This study is the first to investigate the in vivo metabolism of PPT following oral administration by ultra-performance liquid chromatography coupled with electrospray ionization quadrupole time-of-flight tandem mass spectrometry (UPLC-Q/TOF-MS) and nuclear magnetic resonance (NMR) spectroscopy. The structures of the metabolites were identified based on the characteristics of their MS data, MS(2) data, and chromatographic retention times. A total of 22 metabolites, including 17 phase I and 5 phase II metabolites, were found and tentatively identified by comparing their mass spectrometry profiles with those of PPT. Two new monooxygenation metabolites, (20S,24S)-epoxy-dammarane-3,6,12,25-tetraol and (20S,24R)-epoxy-dammarane-3,6,12,25-tetraol, were chemicallly synthesized and unambiguously characterized according to the NMR spectroscopic data.
3.Bioactive protopanaxatriol type saponins isolated from the roots of Panax notoginseng (Burk.) F. H. Chen.
Zhang Y1, Han LF, Sakah KJ, Wu ZZ, Liu LL, Agyemang K, Gao XM, Wang T. Molecules. 2013 Aug 26;18(9):10352-66. doi: 10.3390/molecules180910352.
Seven new protopanaxatriol type saponins, 20S-sanchirhinosides A1 (1), A2 (2), A3 (3), A4 (4), A5 (5), and A6 (6), and sanchirhinoside B (7) were obtained as minor constituents from the root extract of Panax notoginseng (Burkill, F. H. Chen), which showed protection effects against antimycin A induced mitochondrial oxidative stress. Their structures were elucidated by chemical and spectroscopic methods (IR, HRESI-TOF-MS, 1D and 2D NMR). Among them, compounds 4, 6 and 7 showed significant protective effects against antimycin A-induced L6 cell injury.
4.Biotransformation of saponins by endophytes isolated from Panax notoginseng.
Luo SL1, Dang LZ, Li JF, Zou CG, Zhang KQ, Li GH. Chem Biodivers. 2013 Nov;10(11):2021-31. doi: 10.1002/cbdv.201300005.
The biotransformation of the major saponins in Panax notoginseng, including the ginsenosides Rg1, Rh1, Rb1, and Re, by endophytes isolated from P. notoginseng was studied. One hundred and thirty-six endophytes were isolated and screened for their biotransformational abilities. The results showed that five of the tested endophytes were able to transform these saponins. These five strains were identified based on their ITS or 16S rDNA sequences, which revealed that they belonged to the genera Fusarium, Nodulisporium, Brevundimonas, and Bacillus genera. Ten transformed products were isolated and identified, including a new compound 6-O-[α-L-rhamnopyranosyl-(1→2)-β-D-glucopyranosyl]-20-O-β-D-glucopyranosyldammarane-3,6,12,20,24,25-hexaol (3), and nine known compounds, compound K (1), ginsenoside F2 (2), vinaginsenoside R13 (4), vinaginsenoside R22 (5), pseudo-ginsenoside RT4 (6), (20S)-protopanaxatriol (7), ginsenoside Rg1 (8), vinaginsenoside R15 (9), and (20S)-3-O-β-D-glucopyranosyl-6-O-β-D-glucopyranosylprotopanaxatriol (10).
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


CDy9
(CAS: 1800205-57-5)

CDy9, a pyrrolodiazaborinine derivative, has been found to be a fluorescent probe and could be used to detect and isolate intact stem cells.

CAS 937807-66-4 Neurodazine

Neurodazine
(CAS: 937807-66-4)

Neurodazine, a cell-permeable trisubstituted imidazole compound, induces neurogenesis of non-pluripotent C2C12 myoblasts and cells derived from mature human ske...

CAS 271246-66-3 MMK 1

MMK 1
(CAS: 271246-66-3)

MMK 1 is a potent and selective human formyl peptide receptor FPR2 agonist (EC50 = 1, 2 and > 10 000 nM at mFRP2, hFPR2 and hFPR1 respectively). Some findings s...

CAS 1044589-82-3 NITD 008

NITD 008
(CAS: 1044589-82-3)

NITD008 is a flavivirus inhibitor. It was developed as a potential treatment for flavivirus infections, and shows broad spectrum antiviral activity.

CAS 882288-28-0 AI-3

AI-3
(CAS: 882288-28-0)

AI-3 is an antioxidant response element activator and could probably be useful in studies of oxidative stress related diseases.

CAS 53-03-2 Prednisone

Prednisone
(CAS: 53-03-2)

Prednisone (Adasone) is a synthetic corticosteroid agent that is particularly effective as an immunosuppressant compound.

CAS 66-97-7 Psoralen

Psoralen
(CAS: 66-97-7)

Psoralen is an active ingredient from Fructus Psoraleae and has anticancer activity.

CAS 51-79-6 Urethane

Urethane
(CAS: 51-79-6)

Urethane is an ester of carbamic acid used as an antineoplastic agent and for other medicinal purposes.

CAS 51446-62-9 Phosphatidylserine

Phosphatidylserine
(CAS: 51446-62-9)

Phosphatidylserine is a phospholipid, including both amino and fatty acids. It is an acidic (anionic) phospholipid with three ionizable groups. It is an importa...

Brevianamide F
(CAS: 38136-70-8)

Brevianamide F, belongs to a class of naturally occurring 2,5-diketopiperazines, is produced by the fungi A.fumigates and Aspergillus sp.

CAS 163222-33-1 Ezetimibe

Ezetimibe
(CAS: 163222-33-1)

Ezetimibe produces a significant reduction in total cholesterol, LDL cholesterol, and triglycerides as well as a small but significant increase in HDL cholester...

CAS 73-48-3 rac Bendroflumethiazide

rac Bendroflumethiazide
(CAS: 73-48-3)

Bendroflumethiazide is a thiazide diuretic as a Na++Cl- symport inhibitor. Bendroflumethiazide can be used in the treatment of mild heart failure although loop ...

CAS 103300-74-9 Taltirelin Acetate

Taltirelin Acetate
(CAS: 103300-74-9)

Taltirelin Acetate is used in the treatment of spinocerebellar degeneration.Synthetic thyrotropin-releasing hormone (TRH) analog.

CAS 587-63-3 Dihydrokavain

Dihydrokavain
(CAS: 587-63-3)

Dihydrokavain is a kavalactone source from kava beverages used in herbal medicine to treat sleep disturbances, as well as stress and anxiety.

AM-643
(CAS: 1233114-22-1)

AM-643 is an active molecular. In the Biological Tests, it can inhibit FLAP in human whole blood assessed as inhibition of calcium ionophore A23187-induced LTB...

CAS 253449-04-6 Wiskostatin

Wiskostatin
(CAS: 253449-04-6)

Wiskostatin is a cell-permeable and selective inhibitor of neural Wiskott-Aldrich syndrome protein (N-WASP). Wiskostatin directly interacts with the regulatory ...

CAS 221174-33-0 Glyoxalase I inhibitor

Glyoxalase I inhibitor
(CAS: 221174-33-0)

Glyoxalase I inhibitor is a potent Glyoxalase I inhibitor, candidate for anticancer agents.

CAS 55290-63-6 Atractylodin

Atractylodin
(CAS: 55290-63-6)

Atractylodin is an active component of the essential oil contained in the rhizomes of Atractylodes lancea and A.

CAS 1164470-53-4 Sal003

Sal003
(CAS: 1164470-53-4)

Sal003 increases eIF2α phosphorylation status by blocking eIF2a phosphatases in cells.

ONO EI-601
(CAS: 155023-59-9)

ONO EI-601, a sulfonylamine derivative, is one metabolite of ONO-5046 which is a neutrophil elastase inhibitor that could be effective against acute lung injury...

Chemical Structure

CAS 34080-08-5 (20S)-Protopanaxatriol

Quick Inquiry

Verification code

Featured Items